Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer
Completed · Phase 2
Conditions studied: Prostate Cancer
In brief
RATIONALE: Imaging procedures such as MRI may improve the ability to determine the response of prostate tumors to therapy. PURPOSE: Phase II trial to study MRI results in patients with prostate cancer that has been treated with radiation therapy plus androgen suppression therapy.
Key facts
- Study ID
- NCT00002889
- Run by
- Alliance for Clinical Trials in Oncology
- People needed
- 180
- Starts
- 1997-05-01
- Expected to finish
- 2009-06-01
- Last updated by the study team
- 2023-08-18
Who can join
Age: 30 and older. Sex: male. Healthy volunteers: not accepted.
Where it is running
- UCSF Cancer Center and Cancer Research Institute — San Francisco, California, United States
- Walter Reed Army Medical Center — Washington D.C., District of Columbia, United States
- University of Chicago Cancer Research Center — Chicago, Illinois, United States
- Dana-Farber Cancer Institute — Boston, Massachusetts, United States
- Joint Center for Radiation Therapy — Boston, Massachusetts, United States
- St. Joseph's Hospital and Medical Center — Paterson, New Jersey, United States
- Roswell Park Cancer Institute — Buffalo, New York, United States
- Memorial Sloan-Kettering Cancer Center — New York, New York, United States
- Duke Comprehensive Cancer Center — Durham, North Carolina, United States
- Comprehensive Cancer Center of Wake Forest University Baptist Medical Center — Winston-Salem, North Carolina, United States
- Arthur G. James Cancer Hospital - Ohio State University — Columbus, Ohio, United States
- Medical University of South Carolina — Charleston, South Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.